EPISODE · May 15, 2025 · 25 MIN
353: Trump's drug-pricing plan and a potential Theranos 2.0
from The Readout Loud · host STAT
We chat about the mixed sentiment in biotech markets these days and a new blood-testing company formed by Elizabeth Holmes' husband. We also bring on STAT's D.C. correspondent Daniel Payne to talk about President Trump's "most-favored nation" drug pricing policy and health secretary Robert F. Kennedy Jr.'s recent congressional hearing.
Embed this episode
NOW PLAYING
353: Trump's drug-pricing plan and a potential Theranos 2.0
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.